proliferative diabetic retinopathy
Conditions
Interventions
Group 1:vitreoretinal surgery combined with whole retina photocoagulation
Group 2:vitreoretinal surgery combined with anti-VEGF therapy
Sponsors
The Eye Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age=18 years old; (2) type 1 or type 2 diabetes. (3) proliferative diabetic retinopathy with vitreous hemorrhage, and conservative treatment of vitreous hemorrhage without obvious absorption for 1 month requires vitreoretinal surgery; (4) The postoperative refractive medium is clear and the pupil is large enough to obtain sufficient clear fundus.
Exclusion criteria
Exclusion criteria: (1) Previously received panretinal photocoagulation or unfinished panretinal photocoagulation; (2) Pulling retinal detachment involving the macula or the presence of extensive fiber proliferation requires silicone oil filling; (3) anterior chamber neovascularization or neovascular glaucoma; (4) other vascular diseases such as retinal vein occlusion, arterial occlusion, etc; (5) received intraocular anti-VEGF therapy or triamcinolone acetonide treatment which are still in the treatment period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| viusal field; | — |
Secondary
| Measure | Time frame |
|---|---|
| best corrected visual acuity;Electroretinogram;OCT;IOP; | — |
Countries
China
Contacts
Public ContactYong Wei
The Eye Hospital of Wenzhou Medical University
Outcome results
None listed